(APLS) Apellis Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Apellis Pharmaceuticals | (APLS) share price targets
Complete technical analysis of Apellis Pharmaceuticals (APLS) by charts plus indicators, forecast predictions and share price targets for Apellis Pharmaceuticals (APLS)
Apellis Pharmaceuticals trades in USA in Health Care sector.
10 day averaged volume of Apellis Pharmaceuticals is 1928550
| Date | Daily Closing Price | Open | High | Low | Volume |
| 19 Thu Feb 2026 | 22.80 | 22.05 | 22.81 | 21.64 | 1.06 times |
| 18 Wed Feb 2026 | 22.20 | 21.59 | 22.41 | 21.59 | 0.699 times |
| 17 Tue Feb 2026 | 21.57 | 21.68 | 21.93 | 21.30 | 0.79 times |
| 13 Fri Feb 2026 | 21.70 | 22.05 | 22.55 | 21.54 | 1.016 times |
| 13 Fri Feb 2026 | 21.70 | 22.05 | 22.55 | 21.54 | 1.016 times |
| 12 Thu Feb 2026 | 22.05 | 22.23 | 22.38 | 21.72 | 0.694 times |
| 11 Wed Feb 2026 | 22.31 | 22.46 | 22.50 | 21.71 | 0.973 times |
| 10 Tue Feb 2026 | 22.58 | 23.12 | 23.18 | 22.51 | 0.661 times |
| 09 Mon Feb 2026 | 22.83 | 22.94 | 23.69 | 22.70 | 1.679 times |
| 06 Fri Feb 2026 | 23.49 | 22.68 | 23.58 | 22.57 | 0.946 times |
My analysis of stock is bullish for shortterm, but stock is in semi over bought zones and there are some chances of seeing a fall tomorrow. Use 23.1 as stoploss in an intra day sell trade for a target of 22.47. However, stock will show a bullish move above 23.1.
Share price targets for Apellis Pharmaceuticals (APLS)
| Target Type | Value |
| Downside Target | 18.75 |
| Downside Target | 19.25 |
| Downside Target | 20.51 |
| Downside Target | 21.10 |
| Downside Target | 22.55 |
| Upside Target | 23.69 |
| Upside Target | 23.79 |
| Upside Target | 24.10 |
| Upside Target | 26.12 |
| Upside Target | 27.46 |
| Upside Target | 30.48 |
Intraday share price targets for Apellis Pharmaceuticals (APLS)
| Target Type | Value |
| Downside Intraday Target | 21.8 |
| Downside Intraday Target | 20.79 |
| Upside Intraday Target | 23.31 |
| Upside Intraday Target | 23.81 |
| Downside Intraday Target | 22.3 |
Weekly technical analysis of Apellis Pharmaceuticals (APLS)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 19 Thu Feb 2026 | 22.80 | 21.68 | 22.81 | 21.30 | 2.509 times |
| 13 Fri Feb 2026 | 21.70 | 22.05 | 22.55 | 21.54 | 0.202 times |
| 13 Fri Feb 2026 | 21.70 | 22.94 | 23.69 | 21.54 | 0.775 times |
| 06 Fri Feb 2026 | 23.49 | 22.04 | 24.10 | 21.59 | 0.429 times |
| 30 Fri Jan 2026 | 22.58 | 21.72 | 23.79 | 21.10 | 2.901 times |
Price has moved up this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Apellis Pharmaceuticals (APLS)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 19 Thu Feb 2026 | 22.80 | 22.04 | 24.10 | 21.30 | 0.398 times |
| 30 Fri Jan 2026 | 22.58 | 25.09 | 27.46 | 19.26 | 1.575 times |
| 31 Wed Dec 2025 | 25.12 | 21.05 | 26.12 | 20.51 | 1.054 times |
| 28 Fri Nov 2025 | 21.30 | 20.49 | 21.72 | 18.75 | 0.605 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Apellis Pharmaceuticals (APLS)
Price action analysis of Apellis Pharmaceuticals ( (APLS) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Apellis Pharmaceuticals ( (APLS) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Apellis Pharmaceuticals ( (APLS) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Apellis Pharmaceuticals ( (APLS) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Apellis Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Apellis Pharmaceuticals in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Apellis Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Apellis Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Apellis Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 22.37 and Apellis Pharmaceuticals (APLS) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Apellis Pharmaceuticals (APLS) stock. Volume based technical analysis of Apellis Pharmaceuticals (APLS) stock is negative.
Apellis Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Apellis Pharmaceuticals ( (APLS) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Apellis Pharmaceuticals ( (APLS) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Apellis Pharmaceuticals ( (APLS) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Apellis Pharmaceuticals ( (APLS) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Apellis Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Apellis Pharmaceuticals in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Apellis Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Apellis Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Apellis Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 22.37 and Apellis Pharmaceuticals (APLS) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Apellis Pharmaceuticals (APLS) stock. Volume based technical analysis of Apellis Pharmaceuticals (APLS) stock is negative.
Apellis Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.